Cargando…

Effect of a Novel Trivalent Vaccine Formulation against Acute Lung Injury Caused by Pseudomonas aeruginosa

An effective vaccine against Pseudomonas aeruginosa would benefit people susceptible to severe infection. Vaccination targeting V antigen (PcrV) of the P. aeruginosa type III secretion system is a potential prophylactic strategy for reducing P. aeruginosa-induced acute lung injury and acute mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Keita, Kinoshita, Mao, Muranishi, Kentaro, Ohara, Junya, Sudo, Kazuki, Kawaguchi, Ken, Shimizu, Masaru, Naito, Yoshifumi, Moriyama, Kiyoshi, Sawa, Teiji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304393/ https://www.ncbi.nlm.nih.gov/pubmed/37376477 http://dx.doi.org/10.3390/vaccines11061088

Ejemplares similares

Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review
por: Sawa, Teiji, et al.
Publicado: (2014)

Immunoglobulin for Treating Bacterial Infections: One More Mechanism of Action
por: Sawa, Teiji, et al.
Publicado: (2019)

Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs
por: Sawa, Teiji, et al.
Publicado: (2016)

Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia
por: Shimizu, Masaru, et al.
Publicado: (2022)

Epidemiological survey of serum titers from adults against various Gram-negative bacterial V-antigens
por: Kinoshita, Mao, et al.
Publicado: (2020)

TLR4 signaling is essential for survival in acute lung injury induced by virulent Pseudomonas aeruginosa secreting type III secretory toxins
por: Faure, Karine, et al.
Publicado: (2004)

The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response
por: Sawa, Teiji
Publicado: (2014)

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
por: Faure, Karine, et al.
Publicado: (2003)

Preoperative Left Ventricular Energy Loss in the Operating Theater Reflects Subjective Symptoms in Chronic Aortic Regurgitation
por: Kainuma, Atsushi, et al.
Publicado: (2022)

Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance
por: Sawa, Teiji, et al.
Publicado: (2020)

Choice of respiratory therapy for COVID-19 patients with acute hypoxemic respiratory failure: a retrospective case series study
por: Sudo, Kazuki, et al.
Publicado: (2023)

Reduction of the rocuronium-induced withdrawal reflex by MR13A10A, a generic rocuronium with a novel solution: A randomized, controlled study
por: Shimizu, Masaru, et al.
Publicado: (2019)

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017)

Complete Genome Sequence of a Veterinary Pseudomonas aeruginosa Isolate, Pa12
por: Nakamura, Keisuke, et al.
Publicado: (2021)

Cavitary lesions emerged rapidly in Pseudomonas aeruginosa pneumonia
por: Kawakami, Naoki, et al.
Publicado: (2020)

Pseudomonas aeruginosa Resistance to Bacteriophages and Its Prevention by Strategic Therapeutic Cocktail Formulation
por: Vaitekenas, Andrew, et al.
Publicado: (2021)

Impact of Artificial Sputum Medium Formulation on Pseudomonas aeruginosa Secondary Metabolite Production
por: Neve, Rachel L., et al.
Publicado: (2021)

Post-antibiotic effect of orbifloxacin against Escherichia coli and Pseudomonas aeruginosa isolates from dogs
por: Harada, Kazuki, et al.
Publicado: (2012)

Mutant prevention concentration of orbifloxacin: comparison between Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus pseudintermedius of canine origin
por: Shimizu, Takae, et al.
Publicado: (2013)

Difficult tracheal intubation and post-extubation airway stenosis in an 11-month-old patient with unrecognized subglottic stenosis: a case report
por: Ohsima, Natsuko, et al.
Publicado: (2017)

Resistance of Pseudomonas Aeruginosa
por: Graevenitz, Alexander Von
Publicado: (1977)

Pseudomonas aeruginosa Biofilms
por: Thi, Minh Tam Tran, et al.
Publicado: (2020)

Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
por: Lakatos, Kyle, et al.
Publicado: (2020)

Combined Adjuvant Formulations Enhanced an Immune Response of Trivalent Foot and Mouth Disease Vaccine in Cattle
por: Ayele, Getu, et al.
Publicado: (2023)

Quillaja brasiliensis nanoparticle adjuvant formulation improves the efficacy of an inactivated trivalent influenza vaccine in mice
por: Silveira, Fernando, et al.
Publicado: (2023)

Anesthetic management of a pediatric patient with arginase-1 deficiency undergoing strabismus operation: a case report
por: Kato, Hideya, et al.
Publicado: (2019)

The prevalence of Pseudomonas aeruginosa and multidrug resistant Pseudomonas aeruginosa in healthy captive ophidian
por: Sala, Andrea, et al.
Publicado: (2019)

Anesthetic management of a severely obese patient (body mass index 70.1 kg/m(2)) undergoing giant ovarian tumor resection: a case report
por: Yamochi, Shoko, et al.
Publicado: (2022)

The study of formulated Zoush ointment against wound infection and gene expression of virulence factors Pseudomonas aeruginosa
por: Meskini, Maryam, et al.
Publicado: (2018)

Effect of Two Unique Nanoparticle Formulations on the Efficacy of a Broadly Protective Vaccine Against Pseudomonas Aeruginosa
por: Howlader, Debaki R., et al.
Publicado: (2021)

Formulation of water-soluble Buddleja globosa Hope extracts and characterization of their antimicrobial properties against Pseudomonas aeruginosa
por: Araya, Nicolas, et al.
Publicado: (2022)

Energetic performance index improvement after Glenn and Damus-Kaye-Stansel procedure using vector flow mapping analysis: a case report
por: Kainuma, Atsushi, et al.
Publicado: (2020)

Pseudomonas Aeruginosa: Resistance to the Max
por: Poole, Keith
Publicado: (2011)

Biotransformation of myrcene by Pseudomonas aeruginosa
por: Esmaeili, Akbar, et al.
Publicado: (2011)

Cefepime-Resistant Pseudomonas aeruginosa
por: Akhabue, Ehimare, et al.
Publicado: (2011)

The Regulatory Network of Pseudomonas aeruginosa
por: Galán-Vásquez, Edgardo, et al.
Publicado: (2011)

Responses of Pseudomonas aeruginosa to antimicrobials
por: Morita, Yuji, et al.
Publicado: (2014)

Antisense transcription in Pseudomonas aeruginosa
por: Eckweiler, Denitsa, et al.
Publicado: (2018)

Pyometra due to Pseudomonas aeruginosa
por: McLeod, Nathan, et al.
Publicado: (2019)

The multifactorial resistance of Pseudomonas aeruginosa
por: Meliani, Amina
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nuvlrrd8ceks1a1k2o9oapcb72